当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析 - 利润表

亿帆医药

(002019)

  

流通市值:93.11亿  总市值:134.13亿
流通股本:8.51亿   总股本:12.26亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入2,930,281,528.531,944,049,304.17938,532,039.133,836,640,799.74
营业收入2,930,281,528.531,944,049,304.17938,532,039.133,836,640,799.74
二、营业总成本2,757,500,720.621,797,130,144.57892,797,132.613,650,259,130.09
营业成本1,447,589,399.3963,097,074.16480,751,477.191,970,701,402.35
税金及附加33,723,919.8922,340,546.1710,831,847.631,644,840.89
销售费用780,288,516.31507,666,568.21249,727,490.531,040,992,025.58
管理费用278,049,633.51176,825,050.286,182,842.98394,486,844.97
研发费用175,652,095.07109,536,560.7347,510,975.21190,196,603.64
财务费用42,197,156.5417,664,345.117,792,499.122,237,412.66
其中:利息费用58,047,661.8740,817,823.8320,555,558.8785,846,086.07
其中:利息收入10,786,554.849,435,395.85,437,967.8221,386,525.16
加:公允价值变动收益---502,230.73
加:投资收益-12,421,912.45-7,483,572.47-4,767,874.19-18,135,463.6
资产处置收益2,410,590.4902,637.4-136,096.63-556,624.73
资产减值损失(新)-23,395,892.98-15,597,687.71-1,221,138.65-111,542,631.15
信用减值损失(新)-43,820,014.14-37,265,634.16-124,882.34-33,116,930.05
其他收益29,569,692.815,108,665.854,844,318.49120,275,620.8
营业利润平衡项目0000
四、营业利润125,123,271.54102,583,568.5144,329,233.2143,807,871.65
加:营业外收入11,226,214.752,033,369.861,072,516.1320,945,733.17
减:营业外支出1,578,814.31915,263.08160,695.298,016,908.86
利润总额平衡项目0000
五、利润总额134,770,671.98103,701,675.2945,241,054.04156,736,695.96
减:所得税费用33,666,158.1719,029,199.461,250,866.9429,582,745.96
六、净利润101,104,513.8184,672,475.8343,990,187.1127,153,950
持续经营净利润101,104,513.8184,672,475.8343,990,187.1127,153,950
归属于母公司股东的净利润146,845,650.22108,660,386.7564,774,428.2191,277,350.92
少数股东损益-45,741,136.41-23,987,910.92-20,784,241.1-64,123,400.92
(一)基本每股收益0.120.090.050.16
(二)稀释每股收益0.120.090.050.15
八、其他综合收益25,497,648.6560,181,819.72-17,632,901.8377,261,684.69
归属于母公司股东的其他综合收益25,076,787.0960,132,211.21-17,108,117.376,973,341.52
九、综合收益总额126,602,162.46144,854,295.5526,357,285.27204,415,634.69
归属于母公司股东的综合收益总额171,922,437.31168,792,597.9647,666,310.9268,250,692.44
归属于少数股东的综合收益总额-45,320,274.85-23,938,302.41-21,309,025.63-63,835,057.75
公告日期2023-10-312023-08-302023-04-292023-04-15
审计意见(境内)标准无保留意见
TOP↑